PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding

26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...

Read more →

Proposal for the supply of primidone and gabapentin

22 June 2021 - PHARMAC is seeking additional feedback on a proposal to change the funded brands of primidone tablets ...

Read more →

Proposal to fully fund Mercilon 28 for oral contraception

26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...

Read more →

Proposal to widen access to rituximab for treatment of membranous nephropathy

4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...

Read more →

Proposal to widen access to valganciclovir for transplant patients

12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...

Read more →

Proposal to widen access to sirolimus for lymphovascular malformations and tuberous sclerosis complex complications

2 October 2020 - PHARMAC is seeking feedback on a proposal to widen funded access to sirolimus from 1 February ...

Read more →

Proposal to fund emicizumab for people with haemophilia A

18 September 2020 - PHARMAC is seeking feedback on a proposal to fund emicizumab (Hemlibra), a new treatment for people with ...

Read more →

Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule

11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...

Read more →

Proposal to fund an additional brand of budesonide with eformoterol

30 July 2020 - PHARMAC is seeking feedback on a proposal to fund an additional brand (DuoResp Spiromax) of two ...

Read more →

Modifying funded access to mifepristone and misoprostol

2 July 2020 - PHARMAC is pleased to announce a decision to: ...

Read more →

Proposal to award sole supply of infliximab in DHB hospitals

21 May 2020 - PHARMAC is proposing to award sole supply of infliximab, a biologic medicine used to treat a ...

Read more →

Proposal to fund modified release pancreatic enzyme granules (Creon Micro)

2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...

Read more →

PHARMAC seeking views on new cystic fibrosis medicine

24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...

Read more →

Fees and charges proposal 2020-21

20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...

Read more →

Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis

15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...

Read more →